ClinicalTrials.Veeva

Menu

Follow-up of Critical COVID-19 Patients (FUP-COVID)

U

Uppsala University

Status

Unknown

Conditions

AKI
Coagulation Disorder
Inflammatory Response
COVID19
Circulatory Failure
ARDS

Study type

Observational

Funder types

Other

Identifiers

NCT04474249
EPM-2020-02697

Details and patient eligibility

About

The study will follow COVID-19 patients who required intensive care after 3-6 months and one year after discharge from the ICU with functional level as well as organ function to assess recovery after COVID-19. Blood and urine will be collected for biobanking.

Full description

The study will follow COVID-19 patients who required intensive care at Uppsala University Hospital and were included in the Uppsala COVID-19 biobank. The patients will be contacted after three to six months for a first follow-up with assessment of functional level in activities of daily life, psychiatric symptoms, neurological symptoms and working capacity as well as specific organ functions. The organ functions will include circulation, respiration, coagulation, immune function and kidney function. In addition, blood and urine will be collected for biobanking.

Enrollment

300 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • PCR-verified Covid-19
  • Treated in ICU

Exclusion criteria

  • Pregnant of breastfeeding

Trial design

300 participants in 1 patient group

COVID-19
Description:
Patients with PCR-confirmed COVID-19 who were treated in the intensive care unit.

Trial contacts and locations

1

Loading...

Central trial contact

Robert Frithiof, MD. PhD.; Michael Hultström, MD. PhD.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems